{
  "success": false,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "rawResponse": [
    {
      "interventions": [
        {
          "name": "Esketamine",
          "role": "Investigational Product",
          "description": "Intranasal S-enantiomer of ketamine for treatment-resistant depression"
        },
        {
          "name": "Placebo",
          "role": "Placebo",
          "description": "Intranasal placebo solution matching esketamine"
        },
        {
          "name": "Duloxetine",
          "role": "Background Therapy",
          "description": "Oral antidepressant (SNRI) used as active comparator background"
        },
        {
          "name": "Escitalopram",
          "role": "Background Therapy",
          "description": "Oral antidepressant (SSRI) used as active comparator background"
        },
        {
          "name": "Sertraline",
          "role": "Background Therapy",
          "description": "Oral antidepressant (SSRI) used as active comparator background"
        },
        {
          "name": "Venlafaxine XR",
          "role": "Background Therapy",
          "description": "Oral antidepressant (SNRI) used as active comparator background"
        },
        {
          "name": "Midazolam",
          "role": "Rescue Medication",
          "description": "Permitted for agitation or anxiety (max 2.5 mg orally or IM)"
        },
        {
          "name": "Short acting benzodiazepine",
          "role": "Rescue Medication",
          "description": "Permitted post-dose on the day of dosing for agitation or anxiety"
        },
        {
          "name": "Clonidine",
          "role": "Concomitant Medication",
          "description": "Permitted for blood pressure control"
        },
        {
          "name": "Corticosteroids",
          "role": "Concomitant Medication",
          "description": "Intermittent IM/IV/PO permitted with sponsor approval; chronic use prohibited"
        },
        {
          "name": "Opiates",
          "role": "Concomitant Medication",
          "description": "Brief treatment allowed for acute injuries with sponsor approval"
        },
        {
          "name": "Psychostimulants",
          "role": "Concomitant Medication",
          "description": "Prescribed use for non-MDD indications permitted with dosing window restrictions"
        }
      ],
      "products": [
        {
          "name": "Esketamine nasal spray",
          "doseForm": "Solution",
          "strength": "28 mg per device",
          "manufacturer": "Janssen Research & Development"
        },
        {
          "name": "Sertraline",
          "doseForm": "Tablet",
          "strength": "50 mg",
          "manufacturer": "Not specified"
        },
        {
          "name": "Venlafaxine XR",
          "doseForm": "Capsule",
          "strength": "150 mg",
          "manufacturer": "Not specified"
        },
        {
          "name": "Escitalopram",
          "doseForm": "Tablet",
          "strength": "10 mg",
          "manufacturer": "Not specified"
        },
        {
          "name": "Duloxetine",
          "doseForm": "Capsule",
          "strength": "60 mg",
          "manufacturer": "Not specified"
        }
      ],
      "substances": [
        {
          "name": "Esketamine",
          "description": "S-enantiomer of ketamine; NMDA receptor antagonist"
        },
        {
          "name": "JNJ-54135419",
          "description": "Sponsor substance code for esketamine"
        }
      ],
      "administrations": [
        {
          "name": "Esketamine Induction",
          "dose": "56 mg or 84 mg",
          "frequency": "Twice weekly",
          "route": "Intranasal",
          "duration": "4 weeks"
        },
        {
          "name": "Esketamine Optimization/Maintenance",
          "dose": "56 mg or 84 mg",
          "frequency": "Weekly or every other week",
          "route": "Intranasal",
          "duration": "Variable (Maintenance phase)"
        },
        {
          "name": "Oral Antidepressant",
          "dose": "Variable (e.g., Sertraline 50-200mg, Duloxetine 60mg)",
          "frequency": "Once daily",
          "route": "Oral",
          "duration": "Duration of study"
        }
      ],
      "devices": [
        {
          "name": "Intranasal delivery device",
          "manufacturer": "Not specified",
          "purpose": "Self-administration of esketamine or placebo solution"
        }
      ]
    }
  ]
}